Skip to main navigation Skip to search Skip to main content

A Phase 2, multicenter, single-arm, open label study to evaluate the efficacy and safety of AK104 in subjects with recurrent or metastatic cervical cancer

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date18/06/20 → 17/06/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • cervical cancer
  • phase 2 study

Clinical Trial Phase

  • Phase II